Updated:
Norwich Ventures
Norwich is a specialized venture capital firm founded in 2004 with a focus on early-stage medtech. It invests in entrepreneurs developing game-changing...
Norwich Ventures
Norwich is a specialized venture capital firm founded in 2004 with a focus on early-stage medtech. It invests in entrepreneurs developing game-changing technologies that solve large unmet medical needs. It provides initial capital in seed and early-stage rounds and approaches each investment with a long-term perspective.
General information
Firm type
Venture Capital
Year founded
2004
Location
Region
North America
Country
United States
City
Waltham
Corporate office
303 Wyman Street, Suite 300, Waltham, MA 02451, United States
Principals
Aaron Sandoski
Co-Founder and Managing Director
Marlin Miller
Co-Founder and Senior Advisor
Jamie Watkins
Advisor
Sector focus
Frequently asked questions
What is Norwich Ventures' investment stage focus?
Norwich Ventures targets early-stage medical technology companies, providing initial capital in seed and early-stage rounds. The firm states it approaches each investment with a long-term perspective, focusing on companies still proving their initial clinical or technical milestones.
Which medical fields does Norwich Ventures invest in?
The firm is agnostic about the specific field of medicine. Its portfolio history includes companies in electrophysiology, genomics, and women's health. The common investment criteria are a large unmet medical need, best-in-class technology, and a quick path to proof-of-concept, rather than a specific clinical specialty.
Who runs investment decisions at Norwich Ventures?
The firm does not publicly name its general partners or investment committee members on its website. The team's identities and professional backgrounds are not part of its current public-facing materials, and no recent media profiles or LinkedIn page provide this information.
Does Norwich Ventures participate in fund commitments or only direct deals?
Based on available information, Norwich Ventures makes direct investments into early-stage medtech companies. There is no public indication that it commits capital as a limited partner to other venture funds, operating instead as a direct, thesis-driven investor.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on venture capital firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: